STARTMRK. Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial.
Lennox JL, DeJesus E, Lazzarin A, Pollard RB, Madruga JVR, Berger DS, Zhao J, Xu X, Williams-Diaz A, Rodgers AJ, Barnard RJO, Miller MD, DiNubile MJ, Nguyen BY, Leavitt R, Sklar P, for the STARTMRK investigators. Lancet 2009; 374:796-806



Pulse en la Imagen deseada para ampliar



0504092009
Diapositiva2
Diapositiva3
Diapositiva4
Diapositiva5
Diapositiva6
Diapositiva7